| Date |
Report No. |
Title |
| Date Jan. 24, 2011 |
Report No. GAO-11-32 |
Title
United States Government Accountability Office GAO
January 2011 Report to the Ranking Member, Subcommittee on Health, Committee on Veterans’ Affairs, House of Representatives VA HEALTH CARE VA Spends Millions on Post-Traumatic Stress Disorder Research and Incorporates Research Outcomes into Guidelines and Policy for PostTraumatic Stress Disorder Services GAO-11-32 January 2011 VA HEALTH CARE
Acc... |
| Date June 7, 2010 |
Report No. GAO-10-426 |
Title
United States Government Accountability Office GAO
June 2010 Report to Congressional Requesters HOME INFUSION THERAPY Differences between Medicare and Private Insurers’ Coverage GAO-10-426 June 2010 HOME INFUSION THERAPY Highlights
Highlights of GAO-10-426, a report to congressional requesters Accountability Integrity Reliability Differences between Medicare and Private Insurers’ Coverage Why ... |
| Date Dec. 22, 2009 |
Report No. GAO-10-201 |
Title
United States Government Accountability Office GAO
December 2009 Report to Congressional Requesters BRAND-NAME PRESCRIPTION DRUG PRICING Lack of Therapeutically Equivalent Drugs and Limited Competition May Contribute to Extraordinary Price Increases GAO-10-201 December 2009 BRAND-NAME PRESCRIPTION DRUG PRICING Highlights
Highlights of GAO-10-201, a report to congressional requesters Accountability... |
| Date Dec. 17, 2009 |
Report No. GAO-10-125 |
Title
United States Government Accountability Office GAO
December 2009 Report to the Chairman, Subcommittee on Crime, Terrorism, and Homeland Security, Committee on the Judiciary, House of Representatives JUVENILE JUSTICE DOJ Is Enhancing Information on Effective Programs, but Could Better Assess the Utility of This Information GAO-10-125 December 2009 JUVENILE JUSTICE Highlights
Highlights of GAO-10-12... |
| Date Sept. 23, 2009 |
Report No. GAO-09-866 |
Title
United States Government Accountability Office GAO
September 2009 Report to the Ranking Member, Committee on Finance, U.S. Senate NEW DRUG APPROVAL FDA Needs to Enhance Its Oversight of Drugs Approved on the Basis of Surrogate Endpoints GAO-09-866 September 2009 NEW DRUG APPROVAL Highlights
Highlights of GAO-09-866, a report to the Ranking Member, Committee on Finance, U.S. Senate Accountability I... |
| Date April 24, 2008 |
Report No. GAO-08-713T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 10:00 a.m. EDT Thursday, April 24, 2008 Testimony Before the Committee on Education and Labor, House of Representatives RESIDENTIAL PROGRAMS Selected Cases of Death, Abuse, and Deceptive Marketing
Statement of Gregory D. Kutz, Managing Director Forensic Audits and Special Investigations GAO-08-713T April 24, 200... |
| Date Dec. 15, 2005 |
Report No. GAO-06-63 |
Title
United States Government Accountability Office GAO
December 2005 Report to Congressional Committees MEDICARE AND MEDICAID COVERAGE Therapies and Supplies for Inflammatory Bowel Disease GAO-06-63 December 2005 MEDICARE AND MEDICAID COVERAGE Highlights
Highlights of GAO-06-63, a report to congressional committees Accountability Integrity Reliability Therapies and Supplies for Inflammatory Bowel Dise... |
| Date Nov. 10, 2005 |
Report No. GAO-06-59 |
Title
United States Government Accountability Office GAO
November 2005 Report to Congressional Committees MEDICARE Little Progress Made in Targeting Outpatient Therapy Payments to Beneficiaries’ Needs GAO-06-59 November 2005 MEDICARE Highlights
Highlights of GAO-06-59, a report to congressional committees Accountability Integrity Reliability Little Progress Made in Targeting Outpatient Therapy Payment... |
| Date Jan. 14, 2005 |
Report No. GAO-05-220 |
Title
United States Government Accountability Office GAO
January 2005 Report to the Chairman and Ranking Minority Member, Subcommittee on Human Rights and Wellness, Committee on Government Reform, House of Representatives SPECIAL EDUCATION Children with Autism GAO-05-220 United States Government Accountability Office Washington, DC 20548 January 14, 2005 The Honorable Dan Burton Chairman The Honorable D... |
| Date Aug. 12, 2004 |
Report No. GAO-04-709 |
Title
United States Government Accountability Office GAO
August 2004 Report to the Chairman, Committee on Finance, U.S. Senate COMPREHENSIVE OUTPATIENT REHABILITATION FACILITIES High Medicare Payments in Florida Raise Program Integrity Concerns GAO-04-709 August 2004 COMPREHENSIVE OUTPATIENT REHABILITATION FACILITIES
Highlights of GAO-04-709, a report to the Chairman, Committee on Finance, U.S. Senate H... |
| Date April 16, 1997 |
Report No. T-HEHS-97-114 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10 a.m. Wednesday, April 16, 1997 Testimony
Before the Subcommittee on Human Resources, Committee on Government Reform and Oversight, House of Representatives NURSING HOMES Too Early to Assess New Efforts to Control Fraud and Abuse
Statement of Leslie G. Aronovitz, Associate Director Health Financing and Systems Issues... |
| Date Sept. 12, 1996 |
Report No. T-HEHS-96-212 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m. September 12, 1996 Testimony
Before the Subcommittee on Human Resources and Intergovernmental Relations, Committee on Government Reform and Oversight, U. S. House of Representatives PRESCRIPTION DRUGS Implications of Drug Labeling and Off-Label Use
Statement of Sarah F. Jagger Director of Health Services Qua... |
| Date June 11, 1996 |
Report No. AIMD-96-72 |
Title
United States General Accounting Office GAO
June 1996 Report to Congressional Requesters PRESCRIPTION DRUGS AND MEDICAID Automated Review Systems Can Help Promote Safety, Save Money G A O years
1921 - 1996 GAO/AIMD-96-72 GAO United States General Accounting Office Washington, D.C. 20548 Accounting and Information Management Division B-261530 June 11, 1996 The Honorable William F. Clinger, Jr. Chai... |
| Date Sept. 13, 1995 |
Report No. HEHS-95-141 |
Title
United States General Accounting Office GAO
September 1995 Report to the Chairman and Ranking Minority Member, Human Resources and Intergovernmental Relations Subcommittee, House Committee on Government Reform and Oversight CANCER DRUG RESEARCH Contrary to Allegation, NIH Hydrazine Sulfate Studies Were Not Flawed GAO/HEHS-95-141 GAO United States General Accounting Office Washington, D.C. 20548 He... |
| Date Nov. 15, 1994 |
Report No. PEMD-95-9 |
Title
United States General Accounting Office GAO
November 1994 Report to the Chairman, Subcommittee on Human Resources and Intergovernmental Relations, Committee on Government Operations, House of Representatives BREAST CONSERVATION VERSUS MASTECTOMY Patient Survival in Day-to-Day Medical Practice and in Randomized Studies GAO/PEMD-95-9 GAO United States General Accounting Office Washington, D.C. 20548... |
| Date March 7, 1994 |
Report No. PEMD-94-10 |
Title
United States General Accounting Offke GAO
March 1994 Report to the Ranking Minority Member, Subcommittee on Health, Committee on Ways and Means, House of Representatives
/5087/ BONE MARROW TRANSPLANTATION International Comparisons of Availability and Appropriateness of Use GAO/PEMD-94-10 1 Notice: This is a reorint of a GAO reDort. 1 GAO United States General Accounting Office Washington, D.C. 20... |
| Date July 17, 1992 |
Report No. PEMD-92-28 |
Title
.‘ *“I ...J : A0
. “*-“. .-~-_I~ ...” .--. “. _.II vltdy l!l!U MEDICARE Reimbursement Policies Can Influence the Setting and Cost of Chemotherapy RESTRICTED--Not to be released outside the Y General Accounting Office unless specifically approved by the Office of Congressional Relations. United States General Accounting Of’ flce Washington, D.C. 20648 Program Evaluation and Methodolog... |
| Date Dec. 11, 1991 |
Report No. PEMD-92-12 |
Title
~ni&d Siktes General Accounting Office GAO RepO?k ‘the Chaikman, Subc~mittee fo on lt%y~an Resources and Pnteqgwxnmental RelzWms, ~Co~ttee on Government; Operations, U.S. ‘Houseof Repres63jtatives GAO/PElW92-12~ : . . .^. GAO United States General Accounting Office Washington, D.C. 20648 Program Evaluation and Methodology Division B-226468 December 11, 1991 The Honorable Ted Weiss Chairman, Su... |
| Date Dec. 11, 1991 |
Report No. T-PEMD-92-4 |
Title
United States General Accounting Office GAO Testimony
Before the Subcommittee on Human Resources and Intergovernmental Affairs, Committee on Government Operations, House of Representatives For Release on Delivery Expected at 12:00 noon EST Wednesday, December 11,199l BREAST CANCER Progress to Date and Directions for the Future
Statement of Richard L. Linster Director for Planning and Reporting Pro... |
| Date Sept. 27, 1991 |
Report No. PEMD-91-14 |
Title
Reimbursement Policies Constrain Physicians in Their Choice of Cancer Therapies GAO,‘ I~:MI)-9 I’ 1- I4 Program Evaluation and Methodology Division B-24286 1 September 27,lQQl The Honorable Edward M. Kennedy Chairman, Committee on Labor and Human Resources United States Senate Dear Mr. Chairman: At your request, we have studied the prevalence of off-label use of anticancer drugs; how that use ... |
| Date Feb. 28, 1989 |
Report No. PEMD-89-9 |
Title
GAO
February 1989 Report to the Chairman, Subcommittee on-* Health and the Environment, Committee on Energy and Commerce, House of Representatives - BREAST C..NCER Patients’ Survival GAO/PEMD-89-9 About Our New Cover... GAO'S efforts The new color of our report covers represents the latest step in to improve the presentation of our reports. Program Evaluation and Methodology Division B-226468 Fe... |
| Date Oct. 20, 1988 |
Report No. PEMD-89-4BR |
Title
I.. .+ ..‘, . , United States General Accounting Office GAO
October 1988 Briefing Report to the Chairman, Subcommittee on Health and the Environment, Committee on Energy and Commerce, House of Representatives CANCER TREATMENT National Cancer Institute’s Role in Encouraging the Use of Breakthroughs . United States General Accounting Office Washington, D.C. 20548 Program Evaluation and Methodolo... |
| Date Jan. 25, 1988 |
Report No. PEMD-88-12BR |
Title
e on H&&h and the’,, Environment, Committee on Energy and Commerce,House of RepresentativesI ;: _/..
January 1988 CANCER TREATMENT 197&@:- :, . *’ Program Evaluation and Methodology Division B-226468 January 25, 1988 The Bonorable Henry A. Yaxman Chairman, Subcommittee on Health and the Environment Committee on Energy and Commerce !-louse of Representatives Dear Mr. Chairman: One reason often ... |
| Date July 9, 1987 |
Report No. HRD-87-91 |
Title
. United States General kccounting GAO
July 1987 i Report to th&.Administrator, Health Care’ . Financing Administration, Department of ’ Health and Human Services
Office, 1. - MEDICARE 1.. Rehabilitation Service Claims Paid W ithout Adequate Information llllllllH IIIIU
133390 03q3GL
GAO/HRD-87-91 . . B-227482 July 9, 1987 William Roper, M.D. Administrator, Health Care Financing Administration ... |
| Date March 31, 1987 |
Report No. PEMD-87-13 |
Title
*# -*-*4”mI,o-LIImI,--I* m---w- United ----- sljxtes Geueral Accounting --_--1-.-s-- O!fici GAO
0: Report xo the Chairman, Subcominkteeon I;rtte:~governmental IRelationsand Human 13esouxes, Committee on Goverrument Operations, Houseof Representatives CANCER F’ATIENT SURVIVAL What P’rogressHas &en Made?
132697 1 IIII II 1111111 IllIll B-m __- - I_ -(t-_l_---L-_(- iG/PEMD-87-13 , ,,, ,,,, ,,,,... |
| Date Sept. 22, 1981 |
Report No. HRD-81-144 |
Title
UNITED STATES GENERAL ACCOUNTING OFFICE
WAEIHINCTON, D.C. 20548 IIUMAN Rrwunua DIVIWON B-2043139 SEPTEMBER 22,198l The Honorable Edward Madigan, George M. O'Brien, and Henry Waxman House of Repreaentatives Subject: Issues Involved in Amputees' Use of Artificial Limbs (HRD-81-144) 116404 Your October 1, 1980, letter, cosigned by former Congressman Carter, asked u8 to study problema amputees encount... |
| Date April 16, 1981 |
Report No. HRD-81-70 |
Title
UNITED STATES GENERAL ACCOUNTING OFFICE
WASHINGTON, D.C. 20548 I l45!!2~ HUMAN RESC)U??C~ DIVlSlCW B-202636 The Honorable John Leboutillier House of Representatives Dear Mr. Leboutillier: APRIL 16,198l at the Veterans Li- lleged Irregularities Administration Medical Center, Manhattan, New York (HRD-81-70) -‘I Your predecessor requested that we review the Veterans Administration's (VA's) investig... |
| Date April 18, 1975 |
Report No. MWD-75-47 |
Title
‘ REPORT TO THE CONGRESS Controls On Use Of Psychotherapeutic Drugs And Improved Psychiatrist Staffing Are Needed In Veterans Administration Hospitals b BY THE COMPTROLLER GENERAL OF THE UNITED STATES
MWDJ5-47 APRIL18,19?'5 t COMPTROLLER GENERAL
WASHINGTON. OF THE UNITED
D.C. 21XI48 STAlES B-i33044 .To the Presid-ent of the Senate and the Speaker of the House of Representatives We reviewed psych... |
